Integrated analysis for two randomized phase III studies comparing Taxotere at 75 mg/m2 and 100 mg/m2 to control regimens in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based chemotherapy

✍ Scribed by Kim, Y.P; Koch, G; Shepherd, F.A; Fossella, F; Hammershaimb, L; Gamza, F; Rodgers, A; Bizzari, J.-P; Berille, J; Durrleman, S

• Book ID: 118569737
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 108 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80192-0